HARBIN GLORIA PHARMACEUTICALS Co., LTD (SHE:002437)

China flag China · Delayed Price · Currency is CNY
3.360
+0.030 (0.90%)
Mar 10, 2026, 3:04 PM CST
38.84%
Market Cap 7.50B
Revenue (ttm) 2.25B
Net Income (ttm) 293.04M
Shares Out 2.23B
EPS (ttm) 0.13
PE Ratio 26.40
Forward PE 30.55
Dividend n/a
Ex-Dividend Date n/a
Volume 34,073,756
Average Volume 53,063,613
Open 3.260
Previous Close 3.330
Day's Range 3.260 - 3.370
52-Week Range 2.120 - 4.080
Beta 0.27
RSI 50.00
Earnings Date Apr 28, 2026

About SHE:002437

HARBIN GLORIA PHARMACEUTICALS Co., LTD engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. Its products include cardiovascular and cerebrovascular, musculoskeletal, vitamins, electrolyte, diabetes-lowering, analgesics, digestive system and metabolism, anti-infective, and anti-tumor drugs. Harbin Gloria Pharmaceuticals Co., Ltd was founded in 2000 and is based in Harbin, the People’s Republic of China. [Read more]

Sector Healthcare
Founded 2000
Employees 2,703
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002437
Full Company Profile

Financial Performance

In 2024, SHE:002437's revenue was 2.44 billion, a decrease of -7.06% compared to the previous year's 2.63 billion. Earnings were 232.76 million, an increase of 93.43%.

Financial Statements

News

There is no news available yet.